Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Packaging
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Analysis

WuXi AppTec (Shanghai) Co

www.wuxiapptec.com

288 Fute Zhong Road
Waigaoqiao Free Trade Zone
Shanghai
200131
China

+86 21 5046 1111

Activities

Research & Development

Related Companies

  • Piramal Pharma Solutions
  • Lonza
  • PCI Pharma Services
  • Novo Nordisk Pharmatech
  • Nanoform
  • Ecolab Life Sciences
  • Upperton Pharma Solutions
  • Edwards Vacuum
  • Vectorbuilder Inc
  • Merck KGaA
  • Indena
  • Seda Pharmaceutical Development Services
  • Curia
  • Hermes Pharma GmbH
  • Quotient Sciences
  • 3P innovation
  • Starlab
  • Icrom SRL
  • TriRx Pharmaceutical Services
  • Solvias

Related Content

WuXi STA passes EMA pre-approval inspection at Wuxi city site
WuXi STA passes EMA pre-approval inspection at Wuxi city site
WuXi STA launches parenteral formulation manufacturing line
WuXi STA launches parenteral formulation manufacturing line
WuXi STA passes FDA inspection at Shanghai site
WuXi STA passes FDA inspection at Shanghai site
Hoth and WuXi sign API process development agreement
Hoth and WuXi sign API process development agreement
WuXi STA to become preferred CDMO for Coherent Biopharma
WuXi STA to become preferred CDMO for Coherent Biopharma
WuXi STA completes acquisition of drug product manufacturing facility
WuXi STA completes acquisition of drug product manufacturing facility
Aptamer Group and WuXi AppTec collaborate on Optimer therapeutics
Aptamer Group and WuXi AppTec collaborate on Optimer therapeutics
WuXi AppTec completes acquisition of AAV manufacturer Oxgene
WuXi AppTec completes acquisition of AAV manufacturer Oxgene
WuXi STA platform helps Innocare achieve regulatory approval
WuXi STA platform helps Innocare achieve regulatory approval
WuXi STA opens oligonucleotide large-scale manufacturing facility
WuXi STA opens oligonucleotide large-scale manufacturing facility
WuXi STA becomes CDMO partner of Impact Therapeutics
WuXi STA becomes CDMO partner of Impact Therapeutics
CPhI Pharma Awards winners
CPhI Pharma Awards winners
RNA therapeutics to become a dominant treatment within a decade
RNA therapeutics to become a dominant treatment within a decade
WuXi STA Shanghai and Changzhou facilities pass US FDA inspections
WuXi STA Shanghai and Changzhou facilities pass US FDA inspections
Process optimisation with flow chemistry
Process optimisation with flow chemistry
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company